| scholarly article | Q13442814 |
| P50 | author | Viktor Volchkov | Q39034329 |
| Miguel J Martínez | Q47696282 | ||
| Olivier Reynard | Q63488222 | ||
| P2093 | author name string | Olga Dolnik | |
| Valentina A Volchkova | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Orthoebolavirus zairense | Q10538943 |
| 2014 Ebola virus epidemic in Guinea | Q18160902 | ||
| P304 | page(s) | S941-6 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs | |
| P478 | volume | 204 Suppl 3 |
| Q96642669 | A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein |
| Q47159182 | A Single Amino Acid Change in the Marburg Virus Glycoprotein Arises during Serial Cell Culture Passages and Attenuates the Virus in a Macaque Model of Disease |
| Q40249528 | A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein. |
| Q47547522 | Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors |
| Q39004837 | Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulence |
| Q36043153 | An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity |
| Q34593723 | Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation |
| Q27339643 | Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus |
| Q64360507 | Bipartite promoters and RNA editing of paramyxoviruses and filoviruses |
| Q34449079 | Camouflage and misdirection: the full-on assault of ebola virus disease |
| Q36043238 | Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice |
| Q36043284 | Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection |
| Q34461912 | Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells |
| Q40055714 | Ebola Virus Delta Peptide is a Viroporin |
| Q38891399 | Ebola Virus GP Gene Polyadenylation Versus RNA Editing |
| Q36403500 | Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material |
| Q27332250 | Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure |
| Q34500139 | Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection |
| Q35193047 | Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry |
| Q34664182 | Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation |
| Q54221972 | Ebolaviruses: New roles for old proteins. |
| Q34898131 | Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity |
| Q38879034 | Entry of Ebola Virus is an Asynchronous Process. |
| Q40054394 | Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models |
| Q35601783 | Evaluation of perceived threat differences posed by filovirus variants |
| Q40145853 | Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. |
| Q64252161 | Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir |
| Q30244058 | Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry |
| Q41746322 | Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal |
| Q40054473 | Generation of Recombinant Ebola Viruses Using Reverse Genetics |
| Q40158371 | Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus |
| Q23000449 | Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak |
| Q56766050 | Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway |
| Q39436358 | Host Factors Involved in Ebola Virus Replication |
| Q30843053 | In silico-based vaccine design against Ebola virus glycoprotein |
| Q35965936 | Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415". |
| Q36821995 | Integrated sequence and immunology filovirus database at Los Alamos |
| Q59359082 | Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge |
| Q59350581 | Intramuscular Exposure of to Low Doses of Low Passage- or Cell Culture-Adapted Sudan Virus or Ebola Virus |
| Q38940832 | Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity |
| Q34473079 | Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates |
| Q28651528 | Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif |
| Q38868057 | Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig. |
| Q40751484 | Mutational analysis of the Potyviridae transcriptional slippage site utilized for expression of the P3N-PIPO and P1N-PISPO proteins |
| Q30391287 | New Perspectives on Ebola Virus Evolution |
| Q38005664 | Non-canonical translation in RNA viruses |
| Q38857149 | RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor. |
| Q24701776 | Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice |
| Q40056806 | Reverse Genetics Systems for Filoviruses |
| Q26970809 | Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use |
| Q38861989 | Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity |
| Q36239796 | Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus |
| Q36043205 | Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs |
| Q37213985 | Structures of Ebola virus GP and sGP in complex with therapeutic antibodies |
| Q31007853 | The challenge of using experimental infectivity data in risk assessment for Ebola virus: why ecology may be important. |
| Q34869463 | The multiple roles of sGP in Ebola pathogenesis |
| Q36004263 | Transcriptional slippage in the positive-sense RNA virus family Potyviridae |
| Q91838004 | Use of reverse genetics to inform Ebola outbreak responses |
| Q40143248 | VACCINES. Ebola virus vaccines--preparing for the unexpected |
| Q38775636 | Validation of the Filovirus Plaque Assay for Use in Preclinical Studies |
| Q33568288 | Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA |
Search more.